Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects
PHASE1The goal of this interventional study is to evaluate the pharmacokinetics, ...
Location
ICBio Clinical Research Pvt. Ltd.
A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care
PHASE2In December 2019, a novel pneumonia caused by a previously unknown pathogen...
Location
The COVID-19 Unit, Rambam Health Care Campus
101-PGC-005 for the Treatment of COVID-19
PHASE2This is a prospective, randomized, comparative, multi-centric, adaptive des...
Location
Government Medical College & General Hospital